C734-0530 Screening compound: N-(1-benzylpiperidin-4-yl)-2-{1H,4H-chromeno[4,3-c]pyrazol-1-yl}acetamide

C734-0530 Screening compound: N-(1-benzylpiperidin-4-yl)-2-{1H,4H-chromeno[4,3-c]pyrazol-1-yl}acetamide
C734-0530 Screening compound: N-(1-benzylpiperidin-4-yl)-2-{1H,4H-chromeno[4,3-c]pyrazol-1-yl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C734-0530
N-(1-benzylpiperidin-4-yl)-2-{1H,4H-chromeno[4,3-c]pyrazol-1-yl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C734-0530

Molecular Formula

C24H26N4O2 (C24 H26 N4 O2)

Compound Name

N-(1-benzylpiperidin-4-yl)-2-{1H,4H-chromeno[4,3-c]pyrazol-1-yl}acetamide

IUPAC name

N-(1-benzylpiperidin-4-yl)-2-{1H4H-chromeno[43-c]pyrazol-1-yl}acetamide

SMILES

O=C(Cn1ncc2c1-c(cccc1)c1OC2)NC1CCN(Cc2ccccc2)CC1

InChI

InChI=1S/C24H26N4O2/c29-23(26-20-10-12-27(13-11-20)15-18-6-2-1-3-7-18)16-28-24-19(14-25-28)17-30-22-9-5-4-8-21(22)24/h1-9,14,20H,10-13,15-17H2,(H,26,29)

InChI Key

UVSCKNBJNZMXPI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14789646

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

402.5

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.447

Distribution Coefficient, logD

0.889

Water Solubility, LogSw

-2.88

Polar Surface Area

49.644

Acid Dissociation Constant (pKa)

16.35

Base Dissociation Constant (pKb)

8.95

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

C734-0530 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Anti-HIV1 Library (19540 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Antiviral
  • Infections
  • Immune system
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C734-0530 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C734-0530?
Check Price and Availability of C734-0530, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C734-0530 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C734-0530
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C734-0530
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C734-0530 available by request